Synendos Therapeutics is a neuroscience company developing therapies for neuropsychiatric disorders through modulation of the endocannabinoid system. The company is focused on providing safe and effective treatments for conditions such as post-traumatic stress disorder.

Synendos Therapeutics

IPhone / Mobile Compatible

Viewport Meta

SSL by Default

Apple Mobile Web Clips Icon

HSTS

Content Delivery Network

LetsEncrypt

Microsoft Exchange Online

Organization Schema

Business Management

Celine Maeder

Marketing and Product

Sandra Glasmacher

Soren Lemonius

Jutta Heim

Peter Neubeck

Simon Russell

Co-Founder

Andrea Chicca

Co-Founder, Chief Executive Officer and Chief Scientific Officer

Jurg Gertsch

Co-Founder and Head of Scientific Advisory Board

Medical Companies With Fewer Than 1000 Employees (Top 10K)

Medical Companies With Fewer Than 50 Employees (Top 10K)

Europe Startups (Top 10K)

Health Care Companies (Top 10K)

Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders. The company also develops breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of the natural functioning of the brain.

The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the bran. There is a high demand for new pharmacological treatments in this area especially for certain diseases such as post-traumatic stress disorder (PTSD) which has a high unmet medical need.

Ysios Capital

Series A - Synendos Therapeutics

Kurma Partners

Sunstone Life Science Ventures

Venture Kick

Pre Seed Round - Synendos Therapeutics

Grant - Synendos Therapeutics

Allschwil

Basel-Landschaft

Switzerland

Europe

Synendos set to study endocannabinoid inhibitor for ...

Synendos receives EMA nod for brain therapy - PharmaTimes

Synendos Therapeutics Appoints Scientific Advisory Board

Three life sciences startups win CHF 150,000 each

Faster Artery Navigation for Surgeons, Novel Drugs for Stress & Depression, and Heated Infusion Lines to Prevent Hypothermia Win CHF 150,000

A few lessons and thoughts from the Venture Leaders Life Sciences roadshow in Boston, 9-15 June 2019 by Danuta Cichocka

Synendos Looks to Add U.S. Investors to CHF 5-20m Round for Novel Endocannabinoid Inhibitor Drug

The Netherlands

Israel

Asia

United States

North America

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 17, 2024 1:06 PM	e672275e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Sep 17, 2024 10:06 PM	f321992d
company summary	general
signals	general	Sep 17, 2024 1:06 PM	cffbf5af
crunchbase trigger	general	Oct 30, 2024 1:02 PM	cab48016
crunchbase profile	general	Oct 30, 2024 3:02 PM	6b82f626
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	bd66adbf
peers	general	Sep 17, 2024 1:06 PM	9575e640
news basic	general	Sep 17, 2024 1:06 PM	9da2c207
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:SYNENDOS

Synendos Therapeutics